Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer

Clinical trial NCT01354379 · COMPLETED

Trial details

NCT number: NCT01354379
Sponsor: NanoBio Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Volunteers

Start date: 2011-05-01
Primary completion: 2012-06-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.